-
Abdul El-Sayed declares victory in Michigan Senate contest
-
Kuwait marks key events and anniversaries from national history
-
Democrats Seize Congress in Midterm Sweep, Ending Trump Era Control
-
Democrats capture US Congress in sweeping midterm victory
-
Trump congratulates Democrats and signals willingness to cooperate
-
Manchester United rallies past Roma as PSG dominates in Champions League
-
Enel to Install Solar Panels at Niterói Waste Management Facility
-
Qatar prime minister advances mediation through diplomatic calls
-
Qatar sees tentative opening for renewed regional diplomacy
-
Greenland parliament approves security agreement with United States
-
Qatar Tourism joins Pacific Asia Travel Association at London travel market
-
Qatar envoy meets incoming UN General Assembly president
-
Abdul El-Sayed Wins Michigan Senate Seat in Historic Election
-
Trump Signals Willingness to Work With Democrats After Midterm Defeat
-
Qatar media bodies discuss support for humanitarian initiatives
-
Ispire Technology Inc. Schedules Fiscal First Quarter 2027 Earnings Conference Call
-
Dolphin to Host Third Quarter 2026 Earnings Conference Call on Nov 10, 2026
-
Wipeboard Family Launches Free AI Chore Planner That Builds Age-Appropriate Chore Plans in Seconds
-
Medical Care Technologies Inc. (OTCID:MDCE) Moves $250,000 Software Agreement Into Active Development
-
InstaLILY Research Finds One in Six Leaders Across the Supply Chain Faced an AI Incident Involving Supplier or Customer Data
-
PAVS Subsidiary 2Lab3 Launches AniMano+, an AI-Native Digital Entertainment Streaming Platform, on the Apple App Store
-
LightPath Technologies to Host First Quarter Fiscal 2027 Earnings Call on November 10 at 5:00 p.m. Eastern Time
-
Ondas Secures Multi-Million-Dollar Counter-UAS Contracts in Europe and Asia, Accelerating Global Expansion in Aerial Defense
-
QualSights Secures $5 Million Financing and Appoints Prasanna Pitale CEO to Accelerate Company Growth
-
Sidney Resources Secures Federal Approval for Historic Gold and Silver Ore Mobilization
-
Adcore to Publish Third Quarter 2026 Results on November 10, 2026
-
IRS Postpones Texas Tax Deadlines to February 1, 2027 After July Storms - Clear Start Tax Explains What a Disaster Postponement Does Not Pause
-
Dateline and US Government Seek Ninth Circuit Stay
-
Wedgewood Weddings Expands to Maryland With Grey Rock Mansion
-
Worksport Signs Term Sheet to Acquire U.S. Manufactured Truck Bed Accessory Business & Accompanying IP Portfolio
-
Jumia to Announce Third Quarter 2026 Results on November 18, 2026
-
First Canadian Graphite Inc. Closes Flow-Through Financing
-
Apollo Wellness Centers Releases Primer Video
-
RSI Welcomes The Orange County Comptroller's Office as Its Newest Government Premier Partner
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 04
-
Facet Welcomes Three-Time PGA Tour Winner Ben Griffin as Newest Brand Partner
-
SMX Announces Effective Date of Reverse Stock Split
-
ELEKTROS Advances Review of Potential U.S. Lithium Opportunity as Critical Minerals Gain Strategic Momentum
-
Midterm 2026 Healthcare Ballot Results and Impacts Across 13 States: Black Book Research Follow-Up
-
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study
-
Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17
-
ELEKTROS Highlights Northern New York Lithium Potential Amid Growing Focus on Domestic Battery Supply
-
ELEKTROS Brings Lithium Opportunity and Patented EV Charging Technology Into Focus for Investors
-
Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting
-
GoWish Hits 20 Million Registered Users Worldwide and Surpasses 100 Million Wishes Created in the US This Year
-
Cosmos Health's Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve Months
-
Xenetic Biosciences Announces Oral Presentation at 68th ASH Annual Meeting Highlighting DNase I as a Potential Strategy to Overcome CAR T-Cell Resistance
-
Chervon Announces Partnership with Wrestlers in Business Network to Expand Its AMP Talent Program
-
LiveOne (NASDAQ:LVO) Extinguishes $8.5 Million in JGB Debt, Reducing Balance from $17.5 Million to $9 Million
-
Chilean Cobalt Corp. Signs Definitive Option Agreement to Consolidate Substantially All of the Past-Producing La Cobaltera Project Area
Abortion pill at the center of US Supreme Court case
A widely used pill is at the center of the latest legal battle in America's ongoing debate over abortion.
The US Supreme Court heard arguments on Tuesday about restrictions placed by a lower court on mifepristone, which is used for medication abortions.
Here is background on the drug and its use:
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for 63 percent of the abortions in the United States last year, up from 53 percent in 2020.
While the number of medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions accounted for 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
The process in fact involves more than one pill.
The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000 for use up to seven weeks of pregnancy.
Mifepristone was later approved by the FDA for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through other means, such as vacuum aspiration.
The average cost of a medication abortion at Planned Parenthood is $580, but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consultation, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and occur when a fertilized egg grows outside the uterus.
- Where is the pill available? -
Some 20 US states have banned or restricted access to abortion, including medication abortion, since the Supreme Court's ruling in June 2022 overturning the constitutional right to the procedure.
Anti-abortion groups are seeking to restrict access to mifepristone nationwide, including in states where abortion has remained legal, but the Supreme Court appeared reluctant on Tuesday to endorse such a move.
The case before the court concerns limiting the use of mifepristone to the first seven weeks of pregnancy, instead of 10, blocking it from being distributed by mail, and requiring it to be prescribed and dispensed by a doctor.
T.Wright--AT